PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan.\', \'Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, Singapore.\', \'Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran.\', \'Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/03602532.2020.1845201
?:doi
?:hasPublicationType
?:journal
  • Drug metabolism reviews
is ?:pmid of
?:pmid
?:pmid
  • 33138652
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.271
?:rankingScore_hIndex
  • 86
is ?:relation_isRelatedTo_publication of
?:title
  • Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33138652>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33138652>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all